Search Count: 5
 |
Crystal Structure Of Human Dihydroorotate Dehydrogenase In Complex With The Inhibitor 2-Hydroxy-N-(2-Ispropyl-5-Methyl-4-Phenoxyphenyl)Pyrazolo[1,5-A]Pyridine-3-Carboxamide.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2022-10-12 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, IEQ, P6G, ACT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-10-12
Ligands: FMN, ORO, IEQ, P6G, ACT
 |
Crystal Structure Of Aldo-Keto Reductase 1C3 (Akr1C3) Complexed With Inhibitor.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2019-05-08 Classification: OXIDOREDUCTASE Ligands: NAP, FFW, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-05-08
Ligands: NAP, FFW, EDO
 |
Targeting Myeloid Differentiation Using Potent Human Dihydroorotate Dehydrogenase (Hdhodh) Inhibitors Based On 2-Hydroxypyrazolo[1,5-A]Pyridine Scaffold
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.58 Å Release Date: 2018-07-11 Classification: OXIDOREDUCTASE Ligands: DUH, CL, FMN, ACT, ORO, GOL, PGE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-07-11
Ligands: DUH, CL, FMN, ACT, ORO, GOL, PGE
 |
Potent And Selective Aldo-Keto Reductase 1C3 (Akr1C3) Inhibitors Based On The Benzoisoxazole Moiety: Application Of A Bioisosteric Scaffold Hopping Approach To Flufenamic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2018-04-04 Classification: OXIDOREDUCTASE Ligands: NAP, CJ2 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-04-04
Ligands: NAP, CJ2
 |
Potent And Selective Aldo-Keto Reductase 1C3 (Akr1C3) Inhibitors Based On The Benzoisoxazole Moiety: Application Of A Bioisosteric Scaffold Hopping Approach To Flufenamic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2018-04-04 Classification: OXIDOREDUCTASE Ligands: CVN, CL, NAP |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-04-04
Ligands: CVN, CL, NAP